Exclusion Criteria:~1. Significant neurodegenerative disorder of the central nervous system other than
Alzheimer's disease, e.g., Lewy body dementia, Parkinson's disease, multiple sclerosis, progressive
supranuclear palsy, hydrocephalus, Huntington's disease, any condition directly or indirectly caused by
Transmissible Spongiform Encephalopathy (TSE), Creutzfeldt-Jakob Disease (CJD), variant Creutzfeldt-Jakob
Disease (vCJD), or new variant Creutzfeldt-Jakob Disease (nvCJD)~2. The patients has history of seizure (with
the exception of febrile seizures in childhood)~3. Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition - Text Revision (DSM IV-TR) criteria met for any of the following within specified period:~ *
Major depressive disorder (current)~ * Schizophrenia (lifetime)~ * Other psychotic disorders, bipolar disorder,
or substance (including alcohol) related disorders (within the past 5 years)~4. Metal implants in the head
(except dental), pacemaker, cochlear implants, or any other non-removable items that are contraindications to
MR imaging.~5. Evidence of clinically significant disease including but not limited to pulmonary,
gastrointestinal, renal, hepatic, endocrine, cardiovascular or metabolic disorder (Patients with controlled
diabetes, or hypertension, or complete/partial right bundle branch block may be included in the study).~6.
Treatment currently or within 6 months before Baseline with any of the following medications:~ * Typical and
atypical antipsychotics (i.e. Clozapine, Olanzapine)~ * Antiparkinson agents (e.g., levodopa, dopamine
agonists, COMT inhibitors, amantadine, monoamine oxidase B inhibitors, anticholinergics etc)~ * Carbamazepine,
Primidone, Pregabalin, Gabapentin~ * Memantine
